Effects of topical antiglaucoma application on conjunctival impression cytology specimens
- PMID: 16815281
- DOI: 10.1016/j.ajo.2006.02.056
Effects of topical antiglaucoma application on conjunctival impression cytology specimens
Abstract
Purpose: To evaluate the changes in conjunctival impression cytology specimens from patients receiving various topical antiglaucoma medications.
Design: Cross-sectional comparative study.
Methods: Impression cytology specimens were obtained from the eyes taking no topical medication (n = 20) and from the eyes taking various antiglaucoma medications (timolol n = 34; latanoprost n = 40; dorzolamide n = 32; timolol + latanoprost n = 30; timolol + dorzolamide n = 34). Specimens were graded on a scale of zero to three according to Nelson's method.
Results: Cytology scores were significantly higher in the medication group than the control group. Mean cytology scores of the control, timolol, latanoprost, dorzolamide, timolol + latanoprost, and timolol + dorzolamide group were 0.20, 1.62, 2.00, 1.75, 2.13, and 2.44, respectively. Among the medication groups, cytology scores were significantly lower in the monotherapy group than the fixed-combination therapy group.
Conclusions: Various topical antiglaucoma medications induce a significant degree of squamous metaplasia. Conjunctival surface could be altered after the long-term use of antiglaucoma medication.
Similar articles
-
[Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication].Oftalmologia. 2004;48(1):35-42. Oftalmologia. 2004. PMID: 15279417 Clinical Trial. Romanian.
-
Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.Br J Ophthalmol. 2008 Nov;92(11):1498-502. doi: 10.1136/bjo.2008.145219. Epub 2008 Aug 14. Br J Ophthalmol. 2008. PMID: 18703549 Clinical Trial.
-
Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.Ophthalmic Res. 2007;39(1):24-31. doi: 10.1159/000097903. Epub 2006 Dec 11. Ophthalmic Res. 2007. PMID: 17164574 Clinical Trial.
-
[Timolol topical ophthalmic combination].Oftalmologia. 2004;48(1):5-14. Oftalmologia. 2004. PMID: 15279411 Review. Romanian.
-
Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.Expert Opin Pharmacother. 2009 Aug;10(12):2015-24. doi: 10.1517/14656560903124388. Expert Opin Pharmacother. 2009. PMID: 19618994 Review.
Cited by
-
Effects of antiglaucoma drugs on the ocular surface in rabbits: a fixed-combination drug versus two concomitant drugs.Jpn J Ophthalmol. 2011 Nov;55(6):670-5. doi: 10.1007/s10384-011-0078-3. Epub 2011 Sep 9. Jpn J Ophthalmol. 2011. PMID: 21904922
-
Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma.Clin Ophthalmol. 2012;6:673-8. doi: 10.2147/OPTH.S24248. Epub 2012 May 7. Clin Ophthalmol. 2012. PMID: 22654492 Free PMC article.
-
Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography.BMC Ophthalmol. 2020 Jun 19;20(1):244. doi: 10.1186/s12886-020-01518-6. BMC Ophthalmol. 2020. PMID: 32560643 Free PMC article.
-
Bleb Morphology on Anterior-Segment Optical Coherence Tomography after XEN Gel Stent Implantation.J Clin Med. 2023 Oct 25;12(21):6740. doi: 10.3390/jcm12216740. J Clin Med. 2023. PMID: 37959206 Free PMC article.
-
Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy.Front Toxicol. 2023 Jul 21;5:1067942. doi: 10.3389/ftox.2023.1067942. eCollection 2023. Front Toxicol. 2023. PMID: 37547228 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
